ID Logo Medium PNG (Transparent Background).png
UK Court of Appeal rules in favor of InterDigital in dispute with Lenovo
July 12, 2024 09:10 ET | InterDigital, Inc.
WILMINGTON, Del., July 12, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the UK’s Court of...
GREN_LOGO_400px_x_331px.jpg
Ministry of Mines and Energy Grants Licence to Expand Madison Metals’ Khan Mine Development in Namibia, Africa
July 12, 2024 06:50 ET | Madison Metals Inc.
TORONTO, July 12, 2024 (GLOBE NEWSWIRE) -- Madison Metals Inc. (“Madison” or the “Company”) (CSE: GREN) (OTCQB: MMTLF) (FSE: 4EF0) is pleased to announce that the Ministry of Mines and Energy of...
Kane Logo Cropped TransBG.png
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
July 11, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with...
mesologo.png
Mesoblast Resubmits Biologics License Application (BLA) with United States Food & Drug Administration (FDA) for Approval of Ryoncil® in Children with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
July 08, 2024 20:37 ET | Mesoblast Limited
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today it has resubmitted its...
Adeia Logo.png
Adeia Renews Long-Term IP License Agreement with Liberty Global
July 08, 2024 16:05 ET | Adeia Inc.
Adeia Renews Long-Term IP License Agreement with Liberty Global
Lifeist.png
Mikra Applies to Health Canada for CELLF 2.0 NPN
July 08, 2024 07:00 ET | Lifeist Wellness Inc.
Mikra Applies to Health Canada for CELLF 2.0 NPN
Kineta Logo.jpg
Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences
July 08, 2024 06:30 ET | Kineta, Inc.
TuHURA has an exclusive right to negotiate to acquire Kineta’s KVA12123 Immuno-Oncology Drug Program Kineta will receive a $5 million Nonrefundable Payment from TuHURA KVA12123 is currently in a...
CMBRC-1920-Wide.png
CMB Group 91 Receives I-956F Approval in Record 5 Months
July 03, 2024 20:33 ET | CMBRC Services, LLC
DALLAS, July 03, 2024 (GLOBE NEWSWIRE) -- We are thrilled to announce that CMB Group 91 has received its I-956F approval from the United States Citizenship and Immigration Services (USCIS) in less...
TMTG Secures Perpetual Licensing for New Technology in Truth Social TV Streaming and Signs Long-Term Equity Deal
July 03, 2024 16:45 ET | Trump Media & Technology Group
SARASOTA, Fla., July 03, 2024 (GLOBE NEWSWIRE) -- Trump Media & Technology Group Corp. (Nasdaq: DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, yet another of...
Schall Firm Logo 2.jpg
INTC Investors Have the Opportunity to Join Intel Corporation Securities Fraud Investigation with the Schall Law Firm
July 02, 2024 10:20 ET | Schall Law
INTC Investors Have the Opportunity to Join Intel Corporation Securities Fraud Investigation with the Schall Law Firm